These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3279351)

  • 1. Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
    Melis GB; Mais V; Paoletti AM; Beneventi F; Gambacciani M; Fioretti P
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):311-4. PubMed ID: 3279351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cabergoline. Single-dose inhibition of puerperal lactation.
    Caballero-Gordo A; Lopez-Nazareno N; Calderay M; Caballero JL; Mancheño E; Sghedoni D
    J Reprod Med; 1991 Oct; 36(10):717-21. PubMed ID: 1683403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    Melis GB; Gambacciani M; Paoletti AM; Beneventi F; Mais V; Baroldi P; Fioretti P
    J Clin Endocrinol Metab; 1987 Sep; 65(3):541-5. PubMed ID: 3624413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
    Romagnoli S; Milani C; Perin S; Ballabio R; Stelletta C; Mollo A; Gelli D
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():148-51. PubMed ID: 19754555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ; 1991 Jun; 302(6789):1367-71. PubMed ID: 1676318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metergoline as an inhibitor of prolactin release.
    Caballero A; Mena P; Caballero-Díaz JL; Caballero-Asensi A
    J Reprod Med; 1987 Feb; 32(2):115-9. PubMed ID: 3560070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi.
    Buhendwa L; Zachariah R; Teck R; Massaquoi M; Kazima J; Firmenich P; Harries AD
    Trop Doct; 2008 Jan; 38(1):30-2. PubMed ID: 18302861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-lowering effect of acute and once weekly repetitive oral administration of cabergoline at two dose levels in hyperprolactinemic patients.
    Mattei AM; Ferrari C; Baroldi P; Cavioni V; Paracchi A; Galparoli C; Romano C; Spellecchia D; Gerevini G; Crosignani PG
    J Clin Endocrinol Metab; 1988 Jan; 66(1):193-8. PubMed ID: 3275684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cabergoline inhibits prolactin secretion and accelerates involution in dairy cows after dry-off.
    Boutinaud M; Isaka N; Lollivier V; Dessauge F; Gandemer E; Lamberton P; De Prado Taranilla AI; Deflandre A; Sordillo LM
    J Dairy Sci; 2016 Jul; 99(7):5707-5718. PubMed ID: 27179868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lactating sows with the dopamine agonist Cabergoline: effects on LH and prolactin secretion and responses to challenges with naloxone and morphine.
    De Rensis F; Quintavalla F; Foxcroft GR
    Anim Reprod Sci; 1998 May; 51(3):233-47. PubMed ID: 9675405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabergoline: long-acting oral treatment of hyperprolactinemic disorders.
    Ferrari C; Mattei A; Melis GB; Paracchi A; Muratori M; Faglia G; Sghedoni D; Crosignani PG
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1201-6. PubMed ID: 2656736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suppression of puerperal lactation by metergoline].
    Ohkura T; Ohya H; Hosoya N; Mori T; Watanabe H; Masaoka K; Kumasaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):61-7. PubMed ID: 6827165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lactation with lisuride.
    Hardt W; Schmidt-Gollwitzer M; Horowski R
    Gynecol Obstet Invest; 1979; 10(2-3):95-105. PubMed ID: 535777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cabergoline: a new drug for the treatment of hyperprolactinaemia.
    Ferrari C; Piscitelli G; Crosignani PG
    Hum Reprod; 1995 Jul; 10(7):1647-52. PubMed ID: 8582955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of red fox (Vulpes vulpes) fertility with cabergoline: dose response and timing of intervention.
    Marks CA; Jalkanen L; Savolainen R; Short RV
    Reproduction; 2001 Jul; 122(1):147-54. PubMed ID: 11425339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
    Bracco PL; Armentano G; Pellegrini A; Sugliano GC; Tornatore GP
    Minerva Ginecol; 1997 Oct; 49(10):469-73. PubMed ID: 9463181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.